메뉴 건너뛰기




Volumn 50, Issue 9, 2011, Pages 1725-1727

Cryptococcal meningitis in an hiv-negative patient with rheumatoid arthritis treated with rituximab

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; FLUCYTOSINE; INFLIXIMAB; METHOTREXATE; PREDNISONE; RITUXIMAB; VORICONAZOLE;

EID: 80051923113     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker210     Document Type: Letter
Times cited : (20)

References (12)
  • 1
    • 77949571175 scopus 로고    scopus 로고
    • The risk of infections with biologic therapies for rheumatoid arthritis
    • Furst ED. The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 2010;39: 327-46.
    • (2010) Semin Arthritis Rheum , vol.39 , pp. 327-346
    • Furst, E.D.1
  • 2
    • 8444239359 scopus 로고    scopus 로고
    • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial
    • St Clair EW, van der Heijde DM, Smolen JS et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
    • (2004) Arthritis Rheum , vol.50 , pp. 3432-3443
    • St Clair, E.W.1    van der Heijde, D.M.2    Smolen, J.S.3
  • 3
    • 79951712039 scopus 로고    scopus 로고
    • Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
    • Galloway JB, Hyrich KL, Mercer LK et al. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology 2011;50:124-31.
    • (2011) Rheumatology , vol.50 , pp. 124-131
    • Galloway, J.B.1    Hyrich, K.L.2    Mercer, L.K.3
  • 4
    • 57049110415 scopus 로고    scopus 로고
    • Managing cryptococcosis in the immunocompromised host
    • Jarvis JN, Dromer F, Harrison TS et al. Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis 2008;21:596-603.
    • (2008) Curr Opin Infect Dis , vol.21 , pp. 596-603
    • Jarvis, J.N.1    Dromer, F.2    Harrison, T.S.3
  • 6
    • 80051925747 scopus 로고    scopus 로고
    • US Food and Drug Administration. FDA Public Health Advisory: life-threatening brain infection in patients with systemic lupus erythematosus after Rituxan (rituximab) treatment, (January 2010, date last accessed)
    • US Food and Drug Administration. FDA Public Health Advisory: life-threatening brain infection in patients with systemic lupus erythematosus after Rituxan (rituximab) treatment 2006, http://www.fda.gov/cder/drug/advisory/rituximab.htm (January 2010, date last accessed).
    • (2006)
  • 7
    • 47849109050 scopus 로고    scopus 로고
    • Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis
    • Teichmann LL, Woenckhaus M, Vogel C et al. Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology 2008;47:1256-7.
    • (2008) Rheumatology , vol.47 , pp. 1256-1257
    • Teichmann, L.L.1    Woenckhaus, M.2    Vogel, C.3
  • 8
    • 69249232555 scopus 로고    scopus 로고
    • Letter to the editor: cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease
    • Kluger N, Poirier P, Guilpain P et al. Letter to the editor: cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease. Int Soc Infect Dis 2008;13:e325.
    • (2008) Int Soc Infect Dis , vol.13
    • Kluger, N.1    Poirier, P.2    Guilpain, P.3
  • 9
    • 33947710106 scopus 로고    scopus 로고
    • Cryptococcal meningitis in patient treated with infliximab
    • Munoz P, Giannella M, Valerio M et al. Cryptococcal meningitis in patient treated with infliximab. Diagn Microbiol Infect Dis 2007;57:443-6.
    • (2007) Diagn Microbiol Infect Dis , vol.57 , pp. 443-446
    • Munoz, P.1    Giannella, M.2    Valerio, M.3
  • 10
    • 80051931993 scopus 로고    scopus 로고
    • Cartas al Editor -Meningoencefalitis por Cryptococcus neoformans en mujer tratada con rituximab
    • Sanchez-Ojanguren J, Isern-Segura I, Chico-Chumillas C et al. Cartas al Editor -Meningoencefalitis por Cryptococcus neoformans en mujer tratada con rituximab. Med Clin 2009;133:156-8.
    • (2009) Med Clin , vol.133 , pp. 156-158
    • Sanchez-Ojanguren, J.1    Isern-Segura, I.2    Chico-Chumillas, C.3
  • 11
    • 0033855660 scopus 로고    scopus 로고
    • Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment
    • Davis TA, Grillo-Lopez AJ, White CA et al. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol 2000;18: 3135-43.
    • (2000) J Clin Oncol , vol.18 , pp. 3135-3143
    • Davis, T.A.1    Grillo-Lopez, A.J.2    White, C.A.3
  • 12
    • 0037930774 scopus 로고    scopus 로고
    • Delayed-onset neutropenia associated with rituximab therapy
    • Chaiwatanatorn K, Lee N, Grigg A et al. Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol 2003;121:913-8.
    • (2003) Br J Haematol , vol.121 , pp. 913-918
    • Chaiwatanatorn, K.1    Lee, N.2    Grigg, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.